Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yanlun Gu"'
Autor:
Xu He, Abdalla Wedn, Jian Wang, Yanlun Gu, Hongjin Liu, Juqi Zhang, Zhiqiang Lin, Renpeng Zhou, Xiaocong Pang, Yimin Cui
Publikováno v:
Pharmacological Research, Vol 201, Iss , Pp 107063- (2024)
Stimulator of interferon genes (STING) is a crucial innate immune sensor responsible for distinguishing pathogens and cytosolic DNA, mediating innate immune signaling pathways to defend the host. Recent studies have revealed additional regulatory fun
Externí odkaz:
https://doaj.org/article/3144069a7e6c435ab40f7a5760eb2efb
Autor:
Xiaocong Pang, Xiaojiao Sun, Yanlun Gu, Xu He, Kan Gong, Song Song, Jixin Zhang, Jie Xia, Zhenming Liu, Yimin Cui
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/853cc81052f24d9689ec84ed624213d4
Autor:
Xiaocong Pang, Xu He, Zhiwei Qiu, Hanxu Zhang, Ran Xie, Zhiyan Liu, Yanlun Gu, Nan Zhao, Qian Xiang, Yimin Cui
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-42 (2023)
Abstract Integrins are considered the main cell-adhesion transmembrane receptors that play multifaceted roles as extracellular matrix (ECM)-cytoskeletal linkers and transducers in biochemical and mechanical signals between cells and their environment
Externí odkaz:
https://doaj.org/article/7901e8aacd9748bd87c9c408e5d420be
Autor:
Xu He, Juqi Zhang, Mingli Gong, Yanlun Gu, Bingqi Dong, Xiaocong Pang, Chenglong Zhang, Yimin Cui
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundRheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation and gradual joint degeneration, resulting in function disability. Recently, ferroptosis, a novel form of regulated cell death that involves iron-depend
Externí odkaz:
https://doaj.org/article/da26c7be251a434ea6258ce057a9f96e
Autor:
Juqi Zhang, Wenhui Li, Mingli Gong, Yanlun Gu, Hanxu Zhang, Bingqi Dong, Qi Guo, Xiaocong Pang, Qian Xiang, Xu He, Yimin Cui
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objectives: This study aimed to evaluate the risk of venous thrombosis (VTE) associated with Janus kinase (JAK) inhibitors in patients diagnosed with immune-mediated inflammatory diseases.Methods: We conducted a comprehensive search of PUBMED, Cochra
Externí odkaz:
https://doaj.org/article/3560f7f2ea0e4e9c93f892497f8acb82
Autor:
Bingqi Dong, Yingchao Wu, Junling Zhang, Yanlun Gu, Ran Xie, Xu He, Xiaocong Pang, Xin Wang, Yimin Cui
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The majority of gastric cancer (GC) patients are in a progressive stage at the initial stage of treatment, and the overall response rate to immunotherapy remains unsatisfactory largely due to the lack of effective prognostic biomarkers. Immunogenic c
Externí odkaz:
https://doaj.org/article/0a9e207a30054f90924033aeec8e6fc9
The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
Autor:
Yanlun Gu, Bingqi Dong, Xu He, Zhiwei Qiu, Juqi Zhang, Mo Zhang, Haitao Liu, Xiaocong Pang, Yimin Cui
Publikováno v:
Pharmacological Research, Vol 189, Iss , Pp 106694- (2023)
Integrins are main cell adhesion receptors serving as linker attaching cells to extracellular matrix (ECM) and bidirectional hubs transmitting biochemical and mechanical signals between cells and their environment. Integrin αvβ3 is a critical famil
Externí odkaz:
https://doaj.org/article/7bc63064193046cdb1c4a3d336365075
Autor:
Yanlun Gu, Xuedong Shi, Teng Li, Bin-Zhi Qian, Xiaocong Pang, Yimin Cui, Xiaodan Zhang, Xu He, Ran Xie, Ying Zhou, Wei Yu, Junling Zhang
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
The bottleneck arising from castration-resistant prostate cancer (CRPC) treatment is its high metastasis potential and antiandrogen drug resistance, which severely affects survival time of prostate cancer (PCa) patients. Secreted phosphoprotein 1 (SP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a36b63bba7af3b2688ad185b5e1dded
https://pubmed.ncbi.nlm.nih.gov/34721759
https://pubmed.ncbi.nlm.nih.gov/34721759
Autor:
Yanlun Gu, Yimin Cui, Xiaodan Zhang, Zhuo Zhang, Junling Zhang, Wei Yu, Xuedong Shi, Xiaocong Pang, Xu He, Ying Zhou, Teng Li
The bottleneck arising from castration-resistant prostate cancer (CRPC) treatment is its high metastasis potential and anti-androgen drug resistance, which severely affects survival time of prostate cancer (PCa) patients. In our previous study, we fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4694e54aeb68c6a5938f5807a3737e13
https://doi.org/10.21203/rs.3.rs-533801/v1
https://doi.org/10.21203/rs.3.rs-533801/v1
